Yi-Chia Wang1, Chi-Hsiang Huang2, Yu-Kang Tu3. 1. Department of Anaesthesiology, National Taiwan University Hospital, Taipei, Taiwan. 2. Department of Anaesthesiology, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: tee.ntuh@gmail.com. 3. Institute of Epidemiology & Preventive Medicine, College of Public Health, National Taiwan University Hospital, Taipei, Taiwan.
Abstract
BACKGROUND: Measuring mean pulmonary artery pressure by right-heart catheterization is the gold standard for pulmonary hypertension (PH) diagnosis. However, its invasiveness and complication leads to its limited use. The aim of this study was to determine whether echocardiography-derived pulmonary artery acceleration time (PAAT) possesses adequate diagnostic performance for PH, using right-heart catheterization as a reference standard. METHODS: MEDLINE, Embase, PubMed, and the Cochrane Central Register of Controlled Trials were searched through July 2016 for studies evaluating PAAT for the diagnosis of PH. Methodologic quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies tool. For each study, the sensitivity, specificity, and diagnostic odds ratio, along with 95% CIs, were calculated to determine the diagnostic accuracy of PAAT. Meta-regression was conducted to evaluate the impact of potential confounding factors. RESULTS: Of 430 articles, 21 studies (1,280 patients) were identified, including three studies that used transesophageal echocardiography and 18 studies that used transthoracic echocardiography. The pooled sensitivity across studies was 0.84 (95% CI, 0.75-0.90), the pooled specificity was 0.84 (95% CI, 0.78-0.89), and the pooled diagnostic odds ratio was 28 (95% CI, 16-49). The arrhythmia ratio in the population did not affect the specificity of PAAT's diagnostic performance and increased the sensitivity of PH detection. CONCLUSIONS: The results of this study suggest that PAAT is useful for PH detection.
BACKGROUND: Measuring mean pulmonary artery pressure by right-heart catheterization is the gold standard for pulmonary hypertension (PH) diagnosis. However, its invasiveness and complication leads to its limited use. The aim of this study was to determine whether echocardiography-derived pulmonary artery acceleration time (PAAT) possesses adequate diagnostic performance for PH, using right-heart catheterization as a reference standard. METHODS: MEDLINE, Embase, PubMed, and the Cochrane Central Register of Controlled Trials were searched through July 2016 for studies evaluating PAAT for the diagnosis of PH. Methodologic quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies tool. For each study, the sensitivity, specificity, and diagnostic odds ratio, along with 95% CIs, were calculated to determine the diagnostic accuracy of PAAT. Meta-regression was conducted to evaluate the impact of potential confounding factors. RESULTS: Of 430 articles, 21 studies (1,280 patients) were identified, including three studies that used transesophageal echocardiography and 18 studies that used transthoracic echocardiography. The pooled sensitivity across studies was 0.84 (95% CI, 0.75-0.90), the pooled specificity was 0.84 (95% CI, 0.78-0.89), and the pooled diagnostic odds ratio was 28 (95% CI, 16-49). The arrhythmia ratio in the population did not affect the specificity of PAAT's diagnostic performance and increased the sensitivity of PH detection. CONCLUSIONS: The results of this study suggest that PAAT is useful for PH detection.
Authors: Meghna D Patel; Colm R Breatnach; Adam T James; Swati Choudhry; Patrick J McNamara; Amish Jain; Orla Franklin; Aaron Hamvas; Luc Mertens; Gautam K Singh; Afif El-Khuffash; Philip T Levy Journal: J Am Soc Echocardiogr Date: 2019-07 Impact factor: 5.251
Authors: Ryan J Carpenter; Nina Srdanovic; Karen Rychlik; Shawn K Sen; Nicolas F M Porta; Aaron E Hamvas; Karna Murthy; Amanda L Hauck Journal: J Perinatol Date: 2022-04-09 Impact factor: 3.225
Authors: Daniel E Ehrmann; Peter M Mourani; Steven H Abman; Brenda B Poindexter; Lindsey A Morrow; Brandie D Wagner; Michael V Di Maria Journal: J Pediatr Date: 2018-09-21 Impact factor: 4.406
Authors: Jennifer K Trittmann; Hanadi Almazroue; Leif D Nelin; Terri A Shaffer; Charanda R Celestine; Henry W Green; Raphael A Malbrue Journal: Pediatr Res Date: 2021-11-18 Impact factor: 3.953